Glucagon-like peptide-2 inhibits antral emptying in man, but is not as potent as glucagon-like peptide-1

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Standard

Glucagon-like peptide-2 inhibits antral emptying in man, but is not as potent as glucagon-like peptide-1. / Nagell, C F; Wettergren, A; Pedersen, J F; Mortensen, D; Holst, Jens Juul.

I: Scandinavian Journal of Gastroenterology, Bind 39, Nr. 4, 04.2004, s. 353-8.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Harvard

Nagell, CF, Wettergren, A, Pedersen, JF, Mortensen, D & Holst, JJ 2004, 'Glucagon-like peptide-2 inhibits antral emptying in man, but is not as potent as glucagon-like peptide-1', Scandinavian Journal of Gastroenterology, bind 39, nr. 4, s. 353-8.

APA

Nagell, C. F., Wettergren, A., Pedersen, J. F., Mortensen, D., & Holst, J. J. (2004). Glucagon-like peptide-2 inhibits antral emptying in man, but is not as potent as glucagon-like peptide-1. Scandinavian Journal of Gastroenterology, 39(4), 353-8.

Vancouver

Nagell CF, Wettergren A, Pedersen JF, Mortensen D, Holst JJ. Glucagon-like peptide-2 inhibits antral emptying in man, but is not as potent as glucagon-like peptide-1. Scandinavian Journal of Gastroenterology. 2004 apr.;39(4):353-8.

Author

Nagell, C F ; Wettergren, A ; Pedersen, J F ; Mortensen, D ; Holst, Jens Juul. / Glucagon-like peptide-2 inhibits antral emptying in man, but is not as potent as glucagon-like peptide-1. I: Scandinavian Journal of Gastroenterology. 2004 ; Bind 39, Nr. 4. s. 353-8.

Bibtex

@article{75f91571650a4d0382ef90ca5ef97946,
title = "Glucagon-like peptide-2 inhibits antral emptying in man, but is not as potent as glucagon-like peptide-1",
abstract = "BACKGROUND: GLP-1 (glucagon-like peptide-1) and GLP-2 (glucagon-like peptide-2) are released in equimolar amounts in response to meal ingestion. GLP-1 inhibits gastric emptying and reduces postprandial gastric and exocrine pancreatic secretion and may play a physiological regulatory role in controlling appetite and energy intake in humans. The role of GLP-2 is more uncertain. Based on the results of animal studies, it has been suggested that GLP-2 may induce intestinal epithelial growth and inhibit gastric motility. The aim of this study was to determine to what extent GLP-2 alone or together with GLP-1 inhibits gastric emptying and the sensation of hunger in man.METHODS: Eight healthy volunteers were tested in a double-blind, placebo-controlled fashion. Antral emptying of a liquid meal and hunger ratings were determined using ultrasound technology and visual analogue scales scoring during infusions of saline, GLP-2 (0.5, and 1.0 pmol kg body wt(-1) min(-1)), GLP-1 (0.5 pmol kg body wt(-1) min(-1)) or GLP-1 and GLP-2 (0.5 pmol kg body wt(-1) min(-1)).RESULTS: The GLP-2 infusions resulted in a dose-dependent increase in antral emptying time (35%; ns and 75%; P = 0.049) compared to saline, but GLP-2 was less potent than GLP-1, which increased the antral emptying time by 192% (P < 0.001). Addition of GLP-2 to the GLP-1 infusion did not alter the antral emptying time compared with GLP-1 alone. The GLP-1 infusion decreased the sensation of hunger compared with saline (P = 0.023), whereas the two GLP-2 infusions had no significant effect. Addition of GLP-2 to the GLP-1 infusion did not decrease the sensation of hunger further.CONCLUSIONS: Both GLP-1 and GLP-2 inhibit antral emptying in man, but GLP-1 is more potent.",
keywords = "Adult, Female, Gastric Emptying, Gastrointestinal Hormones, Glucagon, Glucagon-Like Peptide 1, Glucagon-Like Peptide 2, Humans, Hunger, Male, Middle Aged, Peptide Fragments, Peptides, Protein Precursors, Pyloric Antrum, Reference Values",
author = "Nagell, {C F} and A Wettergren and Pedersen, {J F} and D Mortensen and Holst, {Jens Juul}",
year = "2004",
month = apr,
language = "English",
volume = "39",
pages = "353--8",
journal = "Scandinavian Journal of Gastroenterology",
issn = "0036-5521",
publisher = "Taylor & Francis",
number = "4",

}

RIS

TY - JOUR

T1 - Glucagon-like peptide-2 inhibits antral emptying in man, but is not as potent as glucagon-like peptide-1

AU - Nagell, C F

AU - Wettergren, A

AU - Pedersen, J F

AU - Mortensen, D

AU - Holst, Jens Juul

PY - 2004/4

Y1 - 2004/4

N2 - BACKGROUND: GLP-1 (glucagon-like peptide-1) and GLP-2 (glucagon-like peptide-2) are released in equimolar amounts in response to meal ingestion. GLP-1 inhibits gastric emptying and reduces postprandial gastric and exocrine pancreatic secretion and may play a physiological regulatory role in controlling appetite and energy intake in humans. The role of GLP-2 is more uncertain. Based on the results of animal studies, it has been suggested that GLP-2 may induce intestinal epithelial growth and inhibit gastric motility. The aim of this study was to determine to what extent GLP-2 alone or together with GLP-1 inhibits gastric emptying and the sensation of hunger in man.METHODS: Eight healthy volunteers were tested in a double-blind, placebo-controlled fashion. Antral emptying of a liquid meal and hunger ratings were determined using ultrasound technology and visual analogue scales scoring during infusions of saline, GLP-2 (0.5, and 1.0 pmol kg body wt(-1) min(-1)), GLP-1 (0.5 pmol kg body wt(-1) min(-1)) or GLP-1 and GLP-2 (0.5 pmol kg body wt(-1) min(-1)).RESULTS: The GLP-2 infusions resulted in a dose-dependent increase in antral emptying time (35%; ns and 75%; P = 0.049) compared to saline, but GLP-2 was less potent than GLP-1, which increased the antral emptying time by 192% (P < 0.001). Addition of GLP-2 to the GLP-1 infusion did not alter the antral emptying time compared with GLP-1 alone. The GLP-1 infusion decreased the sensation of hunger compared with saline (P = 0.023), whereas the two GLP-2 infusions had no significant effect. Addition of GLP-2 to the GLP-1 infusion did not decrease the sensation of hunger further.CONCLUSIONS: Both GLP-1 and GLP-2 inhibit antral emptying in man, but GLP-1 is more potent.

AB - BACKGROUND: GLP-1 (glucagon-like peptide-1) and GLP-2 (glucagon-like peptide-2) are released in equimolar amounts in response to meal ingestion. GLP-1 inhibits gastric emptying and reduces postprandial gastric and exocrine pancreatic secretion and may play a physiological regulatory role in controlling appetite and energy intake in humans. The role of GLP-2 is more uncertain. Based on the results of animal studies, it has been suggested that GLP-2 may induce intestinal epithelial growth and inhibit gastric motility. The aim of this study was to determine to what extent GLP-2 alone or together with GLP-1 inhibits gastric emptying and the sensation of hunger in man.METHODS: Eight healthy volunteers were tested in a double-blind, placebo-controlled fashion. Antral emptying of a liquid meal and hunger ratings were determined using ultrasound technology and visual analogue scales scoring during infusions of saline, GLP-2 (0.5, and 1.0 pmol kg body wt(-1) min(-1)), GLP-1 (0.5 pmol kg body wt(-1) min(-1)) or GLP-1 and GLP-2 (0.5 pmol kg body wt(-1) min(-1)).RESULTS: The GLP-2 infusions resulted in a dose-dependent increase in antral emptying time (35%; ns and 75%; P = 0.049) compared to saline, but GLP-2 was less potent than GLP-1, which increased the antral emptying time by 192% (P < 0.001). Addition of GLP-2 to the GLP-1 infusion did not alter the antral emptying time compared with GLP-1 alone. The GLP-1 infusion decreased the sensation of hunger compared with saline (P = 0.023), whereas the two GLP-2 infusions had no significant effect. Addition of GLP-2 to the GLP-1 infusion did not decrease the sensation of hunger further.CONCLUSIONS: Both GLP-1 and GLP-2 inhibit antral emptying in man, but GLP-1 is more potent.

KW - Adult

KW - Female

KW - Gastric Emptying

KW - Gastrointestinal Hormones

KW - Glucagon

KW - Glucagon-Like Peptide 1

KW - Glucagon-Like Peptide 2

KW - Humans

KW - Hunger

KW - Male

KW - Middle Aged

KW - Peptide Fragments

KW - Peptides

KW - Protein Precursors

KW - Pyloric Antrum

KW - Reference Values

M3 - Journal article

C2 - 15125467

VL - 39

SP - 353

EP - 358

JO - Scandinavian Journal of Gastroenterology

JF - Scandinavian Journal of Gastroenterology

SN - 0036-5521

IS - 4

ER -

ID: 132054469